Protected Graft Copolymer Excipient Leads to a Higher Acute Maximum Tolerated Dose and Extends Residence Time of Vasoactive Intestinal Peptide Significantly Better than Sterically Stabilized Micelles

類似資料

• Extending residence time and stability of peptides by Protected Graft Copolymer (PGC) excipient: GLP-1 example
  著者:: Castillo, Gerardo M., 等
  出版事項: (2011)
• Omeprazole and PGC-formulated heparin binding epidermal growth factor normalizes fasting blood glucose and suppresses insulitis in multiple low dose streptozotocin diabetes model: Omeprazole & growth factor with nanocarrier for Type 1 Diabetes
  著者:: Castillo, Gerardo M., 等
  出版事項: (2013)
• Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs
  著者:: Alexei A. Bogdanov Jr, Mary Mazzanti, Gerardo Castillo, Elijah Bolotin
  出版事項: (2012-01-01)
• Protected Graft Copolymer (PGC) in Imaging and Therapy: A Platform for the Delivery of Covalently and Non-Covalently Bound Drugs
  著者:: Bogdanov Jr, Alexei A., 等
  出版事項: (2012)
• Antiretroviral hydrophobic core graft-copolymer nanoparticles: the effectiveness against mutant HIV-1 strains and in vivo distribution after topical application.
  著者:: Leporati, Anita, 等
  出版事項: (2019)